Panel of experts named to advise Biden on cancer ‘moonshot’

WASHINGTON — More than two dozen leading cancer researchers and advocates will advise Vice President Joe Biden’s cancer moonshot initiative as members of the Blue Ribbon Panel announced by the Obama administration Monday.

They come from top research institutes and cancer centers like the University of Texas MD Anderson Cancer Center and Harvard Medical School, as well as pharmaceutical companies like Pfizer, and advocacy groups like Friends of Cancer Research.

Over the next few months, the panel will develop recommendations for the National Institutes of Health on everything from cancer vaccines to early detection to data sharing. It will also explore what research could be supported by a special funding stream proposed by President Obama in his most recent budget, part of a $755 million plan to fund the cancer initiative.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In